Merseburger, A. S., Baklanova, O., Garlonta, V. T., Androulakis, N. E. M., Christopoulou, A., Timotheadou, E., Demey, W., Janssen, J., Ivanyi, P., Brouwers, B. A. H., Wynendaele, W., Wang, L., Kostkova, L., Hoffman, J., Manzel, A., Koumarianou, A. (2025). Real-world effectiveness and safety of first-line (1L) avelumab + axitinib in patients with advanced renal cell carcinoma (aRCC): Primary analysis of the AVION study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.474